TISSIUM Selected for the French Tech 120 Program
For the fifth year in a row PARIS, FRANCE / ACCESSWIRE / May 22, 2024 / TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, confirms its selection